Latest episode

Episode 6 : Impact of syndromic testing on patient clinical outcom
19:02|In this special ESCMID episode, Dr Shradha Subedi and Dr Umang Agrawal introduce their latest studies on the impact of rapid syndromic testing; one conducted in Australia, the other in India. Together, they discuss how these diagnostics influence clinical decisions, the contrasts in patient management across regions, and the broader implications for the antimicrobial landscape.
More episodes
View all episodes

Episode 5 : ESCMID special – Monitoring Antimicrobial resistance with the Global-PPS
18:16|In this special episode, recorded at ESCMID 2025 in Vienna, we are pleased to welcome two AMR experts: Erika Vlieghe and Ann Versporten. They reveal the impact of the powerful Global Point Prevalence Survey program and highlight its crucial role in tracking antimicrobial use and resistance, sharing rich insights from global implementation
4. Episode 4 : From data to guidelines
21:35||Ep. 4In this episode, we explore AMR in Nigeria and Kenya. Experts highlight the importance of local guidelines in guiding therapy, as empiric treatment remains common. Reliable diagnostic tests and effective data analysis are crucial for developing these guidelines.
3. Episode 3 : The crucial role of Diagnostic Stewardship
21:50||Ep. 3In this episode, two Egyptian experts discuss the crucial role of diagnostics in antimicrobial resistance control. They share success stories, practical strategies, and valuable advice for improving diagnostic stewardship in clinical labs.
2. Episode 2 : Implementation of AMS programs
19:58||Ep. 2In this episode, two Egyptian experts explore the challenges and successes of implementing antimicrobial stewardship programs in their settings. They share practical insights and personal experiences to provide valuable guidance for similar initiatives.
1. Episode 1 : The context of AMR in Egypt
30:39||Ep. 1Two experts dive into the reality of Antimicrobial Resistance in Egypt, discuss the healthcare system and the challenge they face in tackling this silent pandemic.